HomeABDL › Filing
🔔 Get instant alerts when ABDL files quarterly results on BSE Start free trial →

Press Release - Q1FY27

Filed: 23 Jul 2026, 20:26 IST Exchange: BSE Category: Financial Results — Press Release
Press Release - Q1FY27 - Standalone income from operations ₹975 crore +5.3% y-y; EBITDA ₹140 crore +14.4%; PAT ₹68 crore +11.9% - Consolidated income from operations ₹984 crore +5.8% y-y; EBITDA ₹120 crore +1.2%; PAT ₹45 crore -18.7% - Premiumisation drives 10.7% volume growth in Prestige & Above segment in Q1FY27 - International presence expanded to 39 countries; super-premium portfolio growing - India-UK FTA supports margin improvement and premium portfolio sourcing - New product Zoya Pink launched in super-premium gin segment - Manufacturing facility at Rangapur awarded for operational excellence
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 ABDL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add ABDL to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Allied Blenders and Distillers Limited

Important. The summary above is generated automatically from Allied Blenders and Distillers Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.